Lite Strategy, Inc. (LITS) Stock Profile — Insider Trades & Financials

Revenue$0

Net Income-$30.8M

EPS$-1.03

Market Cap$41.5M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Justin File

CEO & Executive Director

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Founded: 2000
Employees: 4
Headquarters: San Diego, California, United States
Website: www.litestrategy.com

⚡

Core Efficiency

ROE?

-37.63%

ROA?

-37.14%

D/E Ratio?

0.01

📊

Profitability Ratios

Current Ratio?

10.04

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

May 15, 2026 (in 36 days)

Quarterly Report (10-Q) — Based on filing pattern

May 15, 2026

Predicted10-Q

Feb 17, 2026

10-QQ2 20258d after period end

Nov 14, 2025

10-QQ1 20256d after period end

Sep 26, 2025

10-KQ4 20253d after period end

May 13, 2025

10-QQ3 202511d after period end

Sep 19, 2024

10-KQ4 20246d after period end

May 9, 2024

10-QQ3 20243d after period end

Feb 13, 2024

10-QQ2 20244d after period end

Nov 9, 2023

10-QQ1 20249d after period end

Loading company sections...

Lite Strategy, Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness